MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-02-2026
Amarin Corporation plc Operating Cycle 2011-2026 | AMRN
Annual Operating Cycle Amarin Corporation plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 213 | 204 | 157 | 146 | 99.6 | 80.5 | 391 | 493 | 337 | 274 | 310 | 298 | 700 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 700 | 80.5 | 285 |
Quarterly Operating Cycle Amarin Corporation plc
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 | 249 | - | 255 | 162 | 201 | - | 169 | 146 | 140 | - | 62.6 | 53.3 | 1.16 K | - | 985 | 813 | 774 | - | 611 | 703 | 428 | 74.2 | 370 | 413 | 472 | 78.5 | 499 | 526 | 494 | 76.8 | 319 | 334 | 86 | 47.1 | 55.7 | 55.1 | 60.4 | 47.4 | 58.7 | 71.2 | 62 | 43.4 | 50.6 | 56.8 | 47.8 | 32.9 | 39.6 | 60.5 | 71 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.16 K | 32.9 | 259 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
115 | $ 20.32 | -1.86 % | $ 2.56 B |  USA |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.82 | -2.7 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
273 | $ 165.39 | -0.6 % | $ 8.23 B | USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 3.65 | -4.58 % | $ 1.09 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
50.2 | $ 0.99 | -2.59 % | $ 72.7 M | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
4.13 | $ 3.18 | -4.94 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M |  Israel |
 |
Agios Pharmaceuticals
AGIO
|
1.74 K | $ 28.47 | -2.5 % | $ 1.65 B | USA |
 |
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
64.6 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
9.78 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
136 | $ 3.64 | -4.21 % | $ 116 M |  France |
 |
Altimmune
ALT
|
15.1 K | $ 4.15 | -0.24 % | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
167 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
174 | - | - | $ 2.91 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
178 | $ 24.06 | 0.75 % | $ 2.94 B | USA |
 |
AbbVie
ABBV
|
350 | $ 231.93 | -0.98 % | $ 410 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
358 | - | - | $ 8.14 B | USA |